Evaluation of diethyldithiocarbamate as a radioprotector of bone marrow
- 1 September 1984
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 10 (9), 1569-1573
- https://doi.org/10.1016/0360-3016(84)90505-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- An explanation for the ability of cytotoxic drug pretreatment to reduce bone marrow related lethality of total body irradiation (TBI)International Journal of Radiation Oncology*Biology*Physics, 1982
- Biphasic Radiosensitization of Human Lymphocytes by Diethyldithiocarbamate: Possible Involvement of Superoxide DismutaseInternational Journal of Radiation Biology, 1980
- Radiosensitization of Human Erythrocytes by DiethyldithiocarbamateInternational Journal of Radiation Biology, 1978
- Protection of normal tissues by WR2721 during fractionated irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1976
- The effect of endotoxin on murine stem cellsJournal of Cellular Physiology, 1973
- Radioprotection of tumor and normal tissues by thiophosphate compoundsCancer, 1973
- Genetic Control of Leucocyte Responses to EndotoxinNature, 1968
- THE GROWTH OF MOUSE BONE MARROW CELLS IN VITROImmunology & Cell Biology, 1966
- Distribution and chemical forms of diethyldithiocarbamate and tetraethylthiuram disulphide (disulfiram) in mice in relation to radioprotectionBiochemical Pharmacology, 1966